213Bi-P-P4D bound specifically to uPAR-overexpressing human monocytic U937 and OV-MZ-6 ovarian cancer cells, as demonstrated by competitive binding studies using pro-uPA, or the soluble receptor form, suPAR. This evidence concerns the gene PLAUR and ovarian carcinoma.